According to NGM Biopharmaceuticals's latest financial reports the company's current earnings are C$4.41 Million. In 2022 the company made an earning of -C$0.23 Billion a decrease over its 2021 earnings that were of -C$0.17 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.